Stock listing
A2JQXP Stock Price, News, Filings & Events — Entera Bio Ltd.
Selected listing: A2JQXP · LS · EUR · DE
This page tracks Entera Bio Ltd.'s A2JQXP:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2JQXP:LS. A2JQXP:LS is the stock-level entry point for investors researching Entera Bio Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2JQXP:LS
- Asset type
- Stock
- Market cap
- $493.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Entera Bio Ltd. A2JQXP:LS stock context
This page tracks Entera Bio Ltd.'s A2JQXP:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2JQXP:LS. A2JQXP:LS is the stock-level entry point for investors researching Entera Bio Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Entera Bio Ltd.
Correction: Entera to Participate in Upcoming Fall Investor Conferences
August 27, 2026
Entera to Participate in Upcoming Fall Investor Conferences
August 27, 2026
Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Init...
August 18, 2026
Entera Announces Second Quarter 2026 Financial Results and Business Updates
August 7, 2026
Entera Bio Phase 2 Data Supporting EB613’s (Oral PTH(1-34)) Anabolic Effect on Postmenopausal Women with Osteoporosis at High Risk for Fr...
August 4, 2026
Entera Bio Ltd. earnings calls
Entera Bio Ltd. (ENTX) Q1 2022 Earnings Call
May 18, 2022 · Replay with transcript and chapters
Entera Bio Ltd. (ENTX) Q4 2021 Earnings Call
March 8, 2022 · Replay with transcript and chapters
Entera Bio Ltd. (ENTX) Q2 2021 Earnings Call
August 16, 2021 · Replay with transcript and chapters
Entera Bio Ltd. (ENTX) Q1 2021 Earnings Call
May 20, 2021 · Replay with transcript and chapters
Entera Bio Ltd. (ENTX) Q4 2020 Earnings Call
March 18, 2021 · Replay with transcript and chapters
Research Entera Bio Ltd.
Entera Bio Ltd. investor report
Review AI stock analysis and investor report context for A2JQXP:LS.
Entera Bio Ltd. company profile
View the public company page for Entera Bio Ltd. on 6ix.
Entera Bio Ltd. news
Read company news and market updates connected to Entera Bio Ltd..
Entera Bio Ltd. investor events
Find investor webinars, events, and replay context for Entera Bio Ltd..
Alternate listings
ENTX:NASDAQ
US · USD
Alternate listing for Entera Bio Ltd.; the primary context on this page is A2JQXP:LS.
A2JQXP:LSX
DE · EUR
Alternate listing for Entera Bio Ltd.; the primary context on this page is A2JQXP:LS.
5DT:SWB
DE · EUR
Alternate listing for Entera Bio Ltd.; the primary context on this page is A2JQXP:LS.
ENTX:BOATS
US · USD
Alternate listing for Entera Bio Ltd.; the primary context on this page is A2JQXP:LS.
5DT:TRADEGATE
DE · EUR
Alternate listing for Entera Bio Ltd.; the primary context on this page is A2JQXP:LS.
5DT:DUS
DE · EUR
Alternate listing for Entera Bio Ltd.; the primary context on this page is A2JQXP:LS.
5DT:FWB
DE · EUR
Alternate listing for Entera Bio Ltd.; the primary context on this page is A2JQXP:LS.
5DT:HAM
DE · EUR
Alternate listing for Entera Bio Ltd.; the primary context on this page is A2JQXP:LS.